490 related articles for article (PubMed ID: 29439070)
1. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
2. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA).
Murphy C; Bennett K; Fahey T; Shelley E; Graham I; Kenny RA
BMJ Open; 2015 Jul; 5(7):e008017. PubMed ID: 26169806
[TBL] [Abstract][Full Text] [Related]
3. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
[TBL] [Abstract][Full Text] [Related]
5. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
6. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
Nilsson G; Samuelsson E; Söderström L; Mooe T
BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
[TBL] [Abstract][Full Text] [Related]
7. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
Fleetcroft R; Schofield P; Ashworth M
BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
[TBL] [Abstract][Full Text] [Related]
8. Time to improve statin prescription guidelines in low-risk patients?
Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
[TBL] [Abstract][Full Text] [Related]
10. Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase.
Seaman KL; Sanfilippo FM; Bulsara MK; Brett T; Kemp-Casey A; Roughead EE; Bulsara C; Preen DB
Aust Health Rev; 2020 Jun; 44(3):377-384. PubMed ID: 32389176
[TBL] [Abstract][Full Text] [Related]
11. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.
Finnikin S; Ryan R; Marshall T
Br J Gen Pract; 2017 Dec; 67(665):e881-e887. PubMed ID: 29061715
[TBL] [Abstract][Full Text] [Related]
12. Age-Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011-2018.
Rhee TG; Kumar M; Ross JS; Coll PP
J Am Geriatr Soc; 2021 May; 69(5):1272-1282. PubMed ID: 33598936
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].
Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C
Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896
[TBL] [Abstract][Full Text] [Related]
14. Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetes.
Lu ZK; Li M; Maxwell WD; Schulz RM
Res Social Adm Pharm; 2016; 12(3):419-27. PubMed ID: 26361822
[TBL] [Abstract][Full Text] [Related]
15. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
16. Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort.
Byrne P; Cullinan J; Gillespie P; Perera R; Smith SM
Br J Gen Pract; 2019 Jun; 69(683):e373-e380. PubMed ID: 31015226
[TBL] [Abstract][Full Text] [Related]
17. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
18. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
19. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
Grimes RT; Ensor J; Bennett K; Henman MC
Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease.
Hope HF; Binkley GM; Fenton S; Kitas GD; Verstappen SMM; Symmons DPM
PLoS One; 2019; 14(1):e0201196. PubMed ID: 30653535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
